Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.

Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z, Koschmieder S, Okuno Y, Dayaram T, Growney JD, Shivdasani RA, Gilliland DG, Speck NA, Nimer SD, Tenen DG.

Nat Genet. 2008 Jan;40(1):51-60. Epub 2007 Nov 11. Erratum in: Nat Genet. 2008 Feb;40(2):255.

PMID:
17994017
2.
3.

AML1 interconnected pathways of leukemogenesis.

Michaud J, Scott HS, Escher R.

Cancer Invest. 2003;21(1):105-36. Review. Erratum in: Cancer Invest. 2003;21(4):659.

PMID:
12643014
4.

Runx1/AML1 in leukemia: disrupted association with diverse protein partners.

Perry C, Eldor A, Soreq H.

Leuk Res. 2002 Mar;26(3):221-8. Review.

PMID:
11792409
5.

Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis.

Saunthararajah Y, Boccuni P, Nucifora G.

Crit Rev Eukaryot Gene Expr. 2006;16(2):183-92. Review.

PMID:
16749897
6.

PU.1: a crucial and versatile player in hematopoiesis and leukemia.

Kastner P, Chan S.

Int J Biochem Cell Biol. 2008;40(1):22-7. Epub 2007 Feb 4. Review.

PMID:
17374502
7.

The RUNX1-PU.1 axis in the control of hematopoiesis.

Imperato MR, Cauchy P, Obier N, Bonifer C.

Int J Hematol. 2015 Apr;101(4):319-29. doi: 10.1007/s12185-015-1762-8. Epub 2015 Mar 8. Review.

PMID:
25749719
8.

Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Koschmieder S, Rosenbauer F, Steidl U, Owens BM, Tenen DG.

Int J Hematol. 2005 Jun;81(5):368-77. Review.

PMID:
16158816
9.

Core binding factor genes and human leukemia.

Hart SM, Foroni L.

Haematologica. 2002 Dec;87(12):1307-23. Review.

10.

Role of PU.1 in hematopoiesis.

Fisher RC, Scott EW.

Stem Cells. 1998;16(1):25-37. Review.

11.

PU.1 and hematopoiesis: lessons learned from gene targeting experiments.

Simon MC.

Semin Immunol. 1998 Apr;10(2):111-8. Review.

PMID:
9618756
12.

Runx1/AML1 in normal and abnormal hematopoiesis.

Yamagata T, Maki K, Mitani K.

Int J Hematol. 2005 Jul;82(1):1-8. Review.

PMID:
16105753
13.

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.

Harada Y, Harada H.

J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. Review.

PMID:
19334039
14.

Core binding factor and its role in normal hematopoietic development.

Speck NA.

Curr Opin Hematol. 2001 Jul;8(4):192-6. Review.

PMID:
11561154
15.

Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?

Dakic A, Wu L, Nutt SL.

Trends Immunol. 2007 Mar;28(3):108-14. Epub 2007 Jan 30. Review.

PMID:
17267285
16.

Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.

DeKoter RP, Kamath MB, Houston IB.

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):316-20. Epub 2007 Jul 13. Review.

17.

Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.

Ichikawa M, Asai T, Chiba S, Kurokawa M, Ogawa S.

Cell Cycle. 2004 Jun;3(6):722-4. Epub 2004 Jun 28. Review.

PMID:
15213471
19.

A role for RUNX1 in hematopoiesis and myeloid leukemia.

Ichikawa M, Yoshimi A, Nakagawa M, Nishimoto N, Watanabe-Okochi N, Kurokawa M.

Int J Hematol. 2013 Jun;97(6):726-34. doi: 10.1007/s12185-013-1347-3. Epub 2013 Apr 24. Review.

PMID:
23613270
20.

Surprising new roles for PU.1 in the adaptive immune response.

Carotta S, Wu L, Nutt SL.

Immunol Rev. 2010 Nov;238(1):63-75. doi: 10.1111/j.1600-065X.2010.00955.x. Review.

PMID:
20969585

Supplemental Content

Support Center